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Abstract
Background: Shoulder arthroplasty is associated with significant post- operative pain. 
Interscalene plexus block is the gold standard for pain management in patients under-
going this surgery, however, alternatives are currently being developed. We hypoth-
esized that a combination of anterior suprascapular nerve block and lateral sagittal 
infraclavicular block would provide effective post- operative analgesia. Primary aims 
for this study were to document numeric rating scale (NRS) pain score and use of oral 
morphine equivalents (OMEq) during the first 24 hours after surgery. Secondary aim 
was to determine the incidence of hemidiaphragmatic paralysis.
Methods: Twenty patients (ASA physical status I- III) scheduled for shoulder arthro-
plasty were studied. Four mL ropivacaine 0.5% was administered for the suprascapu-
lar nerve block and 15 mL ropivacaine 0.75% for the infraclavicular block. Surgery 
was performed under general anaesthesia. Paracetamol and prolonged- release oxy-
codone were prescribed as post- operative analgesics. Morphine and oxycodone were 
prescribed as rescue pain medication. Diaphragm status was assessed by ultrasound.
Results: Median NRS (0- 10) at 1, 3, 6, 8 and 24 hours post- operatively were 1, 0, 
0, 0 and 3, respectively. NRS at rest during the first 24 post- operative hours was 4 
(2.5- 4.5 [0- 5]), median (IQR [range]). Maximum NRS was 6.5 (5- 8 [0- 10]) median (IQR 
[range]). Total OMEq during the first 24 post- operative hours was 52.5 mg (30- 60 
[26.4- 121.5]) median (IQR [range]). Hemidiaphragmatic paralysis was diagnosed in 
one patient (5%).
Conclusions: The combination of suprascapular and infraclavicular nerve block shows 
an encouraging post- operative analgesic profile and a low risk for hemidiaphragmatic 
paralysis after total shoulder arthroplasty.
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1  | INTRODUC TION
Shoulder surgery is frequently associated with high levels of post- 
operative pain, which may require analgesia with opioids for several 
days.1 The use of regional anaesthetic techniques is therefore rec-
ommended. Interscalene brachial plexus block is currently the gold 
standard for intraoperative and post- operative pain management 
in patients undergoing shoulder surgery. However, in recent years 
there has been increasing research into alternatives to the classic 
interscalene block due to a wide spectrum of complications, with 
the risk of hemidiaphragmatic paresis of prominent interest.2- 5 The 
innervation of the shoulder joint is provided by several nerves6,7: 
subscapular, axillary, lateral pectoral and suprascapular nerve. The 
subscapular, axillary and lateral pectoral nerve can be blocked with 
a single injection as distal as at the cord level with the infraclavicular 
block, while the suprascapular nerve must be blocked separately. In 
a previous randomized placebo- controlled study,8 we explored the 
effects of an anterior suprascapular block (SSNB) in patients under-
going hand surgery under regional anaesthesia, provided by a lateral 
sagittal infraclavicular block (LSIB). The diaphragmatic function was 
assessed by chest x- ray and none of the 15 patients showed any sign 
of ipsilateral phrenic palsy. We have also showed that a combina-
tion of peripheral nerve blocks allowed patients to undergo arthro-
scopic shoulder surgery without the need for opioids or an artificial 
airway.9 The patients received a combination of superficial cervical 
plexus block, SSNB and LSIB. More recently, we have determined 
the minimum effective local anaesthetic volume needed to block 
shoulder relevant nerves with the LSIB- method.10 Data indicated a 
significantly reduced total volume of local anaesthetics needed to 
anesthetize the shoulder. Accordingly, we hypothesized that a com-
bination of anterior suprascapular nerve block and lateral sagittal 
infraclavicular block of the posterior and lateral cords would provide 
effective post- operative analgesia for patients undergoing shoulder 
arthroplasty. Primary aims for the current study were to document 
numeric rating scale (NRS) and use of oral morphine equivalents 
(OMEq) during the first 24 hours after surgery. Secondary aim was 
to determine the incidence of ipsilateral hemidiaphragmatic paraly-
sis 30 minutes after the blocks.
2  | METHODS
In this prospective case series, 20 patients scheduled for shoul-
der arthroplasty were included. The study was approved by the 
Institutional Boards at the University Hospital of North Norway 
(registration number 2018- 2081 REK Nord, 2nd November 2018), 
Nordland Hospital in Bodø (registration number 02- 19, 28th January 
2019), and Sørlandet Hospital in Kristiansand (registration number 
01- 20, 15th January 2020). It was also registered at www.clini caltr 
ials.gov (registration number NCT 03877835, 18th March 2019). The 
study was performed at the University Hospital of North Norway 
in Tromsø, Nordland Hospital in Bodø, and Sørlandet hospital in 
Kristiansand, from March 2019 to August 2020, in accordance with 
the Helsinki Declaration. Written informed consent was obtained 
and the following inclusion criteria were applied: 18- 80 years old, 
BMI 20- 35 kg m−2 and ASA physical status 1- 3. Exclusion criteria 
included: pregnancy, severe respiratory disease, use of anticoagu-
lation drugs other than acetylsalicylic acid or dipyridamole, allergy 
to local anaesthetics, patients on regular opioids, atrioventricular 
block, pacemaker and peripheral neuropathy.
All patients received oxygen supplementation by a nasal cannula. 
No premedication was given. Standard monitoring included pulse 
oximetry, electrocardiogram and non- invasive blood pressure.
All blocks were performed by DM. LMY assessed neurological 
status in all patients, before and 30 minutes after the block, but 
was not present during the procedure. The patients were placed su-
pine with slightly elevated upper body. All blocks were ultrasound- 
guided, using a SonoSite S- II unit (SonoSite, Inc). A 38 mm linear array 
probe 6- 13 MHz was applied. The initial needle insertion counted as 
the first pass. Moreover, a nerve stimulator response by a current 
≤0.3 mA, 0.1 ms and 2 Hz defined the need for a small retraction of 
the needle. Additional passes were defined as needle advancement 
upon a retraction of at least 10 mm. A pre- scan was carried out to 
optimize the settings of the ultrasound apparatus. Skin preparation 
was performed using chlorhexidine 0.5%. The probe was covered 
with a sterile transducer cover and sterile ultrasound gel was used. 
A skin wheal was raised with 1- 2 mL lidocaine 1% before insertion 
of an ultrasound echogenic 22G × 80 mm needle (PAJUNK® GmbH 
Medizintechnologie, Geisingen, Germany).
The supraclavicular approach to the suprascapular block was 
first described by Siegenthaler et al.11 The suprascapular nerve is 
usually the most craniolateral nerve emerging from the supracla-
vicular brachial plexus. The ultrasound probe was placed on the su-
praclavicular fossa to identify the brachial plexus. Subsequently, the 
plexus was followed proximally until the suprascapular nerve was 
observed branching from the superior trunk. The nerve was then 
followed back distally, until it was visualized deep to the omohyoid 
muscle. The local anaesthetic was injected at the most lateral trans-
verse view of the nerve that could be obtained with the in- plane 
technique, while advancing the needle from posterolateral to an-
teromedial. The local anaesthetic dose was 4 mL ropivacaine 0.5%.
For the infraclavicular block of the posterior and lateral cord, the 
needle insertion point was 0.5- 1.0 cm caudal to the lower edge of 
the clavicle, just medial to the coracoid process. Needle advance-
ment was in the parasagittal plane, with continuous observation of 
the needle tip, using the in- plane technique. Considering the artery 
as a clock face with 12 o΄clock ventral, the local anaesthetic was 
Editorial Comment
There is no generally agreed upon single approach to re-
gional anaesthesia for shoulder arthroplasty. In this pro-
spective series, a combination of two blocks is examined, 
and found to be promising.
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injected as a single deposit of 15 mL ropivacaine 0.75% between 8 
and 9 o'clock.10
Total block performance time was defined as the time interval 
between contact of the ultrasound probe with the patient for the 
suprascapular block and the withdrawal of the needle for the infra-
clavicular block. Dexamethasone (4 mg) was administrated intrave-
nously, as a block adjuvant, after the completed block procedure.
Subsequently, all patients underwent general anaesthesia with 
endotracheal intubation using target- controlled infusion (TCI) anaes-
thesia with propofol and remifentanil. During the surgery all subjects 
were placed in the beach chair position and no other opioids were 
administrated. The surgical incision was infiltrated with 20 mL bupiv-
acaine 0.25% with adrenaline 5 μg mL−1 at the end of surgery.
All patients received 1 g paracetamol four times daily and 10 mg 
prolonged- release oxycodone tablets twice a day. First dose was 
given post- operative at 6:00 pm In the post- anaesthesia care unit 
(PACU), rescue pain medication was given as intravenous morphine. 
In the hospital ward, rescue pain medication was given as oxyco-
done, either orally or intravenously.
2.1 | Block assessment
Sensory- motor status of the upper limb was assessed by LMY before 
the blocks and 30 minutes after block completion. Sensory testing 
was performed by applying an ice cube to the cutaneous innervation 
areas of the axillary and musculocutaneous nerves. The following 
scale was used: 3 = normal cold feeling; 2 = reduced cold feeling (hy-
poalgesia); 1 = no cold feeling, but feels touch (analgesia); and 0 = no 
cold or touch feeling (anaesthesia).
Muscle power was assessed using a modified seven- point scale 
(Table 1).12 The suprascapular nerve block was tested by the force 
for lateral rotation of the humerus against manual resistance, while 
the arm was adducted and the elbow flexed at 90°.
Block success was assessed 30 minutes after withdrawal of the 
needle from the last of the two blocks. The block combination was 
considered successful if it met the following three criteria: (a) the su-
prascapular nerve block had a motor score ≤4−; (b) the axillary nerve 
sensory score was 0 or 1; (c) the musculocutaneous nerve sensory 
score was 0 or 1, or if the motor score was ≤4−. As previously men-
tioned, the suprascapular and the axillary nerves are of direct in-
terest for the anaesthesia of the shoulder. The musculocutaneous 
nerve test was used as a surrogate test for the lateral cord, where 
the lateral pectoral nerve is of most interest. Since anastomoses 
between the median and musculocutaneous nerves13 may interfere 
with sensory testing of the lateral cord, the lateral cord block was 
judged with both a sensory and a muscle power score.
The incidence of adverse events was recorded, including paraes-
thesia, vessel puncture, systemic local anaesthetic toxicity, Horner's 
syndrome, dyspnoea, hoarseness and dysphagia. A lung ultrasound 
scan was performed within 15 minutes after completed procedure 
to look for signs of pneumothorax.
Diaphragm status was assessed by a blinded investigator (LMY) 
with the use of ultrasound before and 30 minutes after the blocks 
were performed. A 2- 5 MHz curvilinear US transducer (SonoSite, 
Inc) were used in all subjects; the liver and spleen served as acoustic 
windows on the right and left side, respectively. Hemidiaphragmatic 
paralysis was defined as the absence of diaphragmatic motion during 
normal respiration, coupled with absent or (paradoxical) cranial dia-
phragmatic movement when the patient forcefully sniffed. Patients 
with a positive ultrasound scan underwent a chest x- ray to confirm 
the diagnosis.
2.2 | Post- operative assessment
NRS (0- 10) pain score was recorded at 1, 3, 6, 8 and 24 hours 
after arrival to the PACU. Occurrence of post- operative nausea 
and vomiting (PONV) in the PACU was registered. All patients 
were interviewed by DM after the first post- operative day and 
opioid consumption was converted to OMEq.14 Static median NRS 
pain score and maximum NRS pain score during the first 24 post- 
operative hours were recorded. Conversion factors are presented 
in Table 2.
As this study was an exploratory case series, no formal power 
calculation was performed. A priori, it was decided that the inclu-
sion of 20 patients would provide sufficient information to serve as 
a hypothesis- generating data source. Descriptive characteristics are 
presented as mean (standard deviation), median (interquartile range 
and range) or number, as appropriate. Analyses were performed 
using the Statistical Package for Social Sciences (SPSS) program ver-
sion 26.0 for Windows (SPSS Inc).
3  | RESULTS
Twenty- eight consecutive patients scheduled for shoulder arthro-
plasty were screened. Of these, 20 patients fulfilled the inclusion 
5 Normal power
4+ Active movement against gravity and resistance (>50% of normal power)
4− Active movement against gravity and resistance (<50% of normal power)
3 Active movement against gravity
2 Active movement with gravity eliminated
1 Flicker or trace contraction
0 No contraction
TA B L E  1   Modified Medical Research 
Council scale of muscle power1
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criteria (Tromsø: 9, Bodø: 9, Kristiansand: 2). One patient did not re-
ceive total arthroplasty and was therefore excluded from the data 
analyses. Consort flow diagram is presented in Figure 1. Patient 
characteristics are presented in Table 3.
The block combination was successful in 18 of 19 patients (95%) 
after 30 minutes. The failed block was due to late onset of the SSNB 
in patient #6, but met the success criteria after 35 minutes. We ap-
plied the intention- to- treat principle and therefore included all 19 
patients in the subsequent analyses.
Time to pain onset was 12.7 (0- 19.5 [0- 21.7]) median (IQR [range]) 
hours. During the first 24 hours, pain score at rest was 4 (2.5- 4.5 [0- 5]), 
median (IQR [range]). Maximum pain score was 6.5 (5- 8 [0- 10]) median 
(IQR [range]). Median NRS values 1, 3, 6, 8 and 24 hours after arrival 
to the PACU are shown in Figure 2. Cumulative OMEq over time, with 
and without the scheduled prolonged- release oxycodone, are shown 
in Table 4. Median consumption of OMEq during the first 24 post- 
operative hours was 52.5 (30- 60 [26.4- 121.5]) (IQR [range]) mg.
None of the patients reported dysphagia, dyspnoea and hoarse-
ness. No cases of Horner's syndrome were observed and none of 
the patients showed ultrasonographic signs of pneumothorax. One 
patient (5%) was diagnosed with hemidiaphragmatic paralysis, which 
was confirmed by chest x- ray. Hemidiaphragmatic function resumed 
when the local anaesthetic effect had worn off, and this was docu-
mented by a new chest x- ray on the first post- operative day.
Individual block data are presented in Table 5. Total block per-
formance time was 7.2 (6.8- 7.8 [6.3- 10.5]), median (IQR [range]) 
minutes. Time from end of local anaesthetic injection until the first 
NRS measurement was 6.7 (5.3- 7.4 [4.6- 9.3]), median (IQR [range]) 









Note: Adapted from Nielsen et al2
F I G U R E  1   Consort flow diagram 
[Colour figure can be viewed at 
wileyonlinelibrary.com]
TA B L E  3   Characteristics of study patients scheduled for total 
shoulder arthroplasty (n = 19)
Age (yr) 69.9 (5.2)
gender (male/female) 10/9
Body mass index; kg m−2 29.2 (2.6)
ASA physical status (I/II/III) 1/15/3
Types of prothesis (anatomic/reverse) 9/10
Side (right/left) 7/12
Note: Continuous variables are presented as mean (standard deviation); 
categorical variables are presented as counts.
Abbreviation: ASA, American Society of Anaesthesiologists.
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hours. The median duration of surgery was 1.8 (1.7- 2.5 [1.5- 3.2]) 
(IQR [range]) hours.
In the PACU, no patient suffered from PONV. Three patients re-
quired intravenous morphine and mean NRS in this group of patients 
was 3.5. The mean morphine dose administered to these three pa-
tients was 5.1 mg.
4  | DISCUSSION
In this case series, we explored a combination of an infraclavicular 
brachial plexus block and anterior suprascapular nerve block in 20 
patients receiving total shoulder arthroplasty surgery under general 
anaesthesia. A successful block was achieved in 95% of patients, 
with short performance time and a good safety profile. We reported 
one case of hemidiaphragmatic paralysis (5%). The median NRS pain 
score at 1, 3, 6 and 8 hours post- operatively were low, though a no-
ticeable increase in score was observed after the nerve blocks wore 
off. Median use of OMEq during the first 24 post- operative hours 
was 52.5 mg.
In recent years, we have witnessed an increasing interest in al-
ternative peripheral nerve blocks to provide analgesia for shoulder 
F I G U R E  2   NRS at different timepoints. Boxplot showing median, quartiles, range and outliers [Colour figure can be viewed at 
wileyonlinelibrary.com]
TA B L E  4   Cumulative doses of rescue OMEq and total OMEq 
over time. Values are median (IQR [range])
PACU 0- 8 hrs 0- 24 hrs
Rescue OMEq 0 (0- 0 [0- 24]) 0 (0- 0 
[0- 31.5])
22.5 (7.5- 30 
[0- 91.5])
Total OMEq 0 (0- 0 [0- 24]) 15 (15- 15 
[15- 46.5])
52.5 (30- 60 
[26.4- 121.5])
Note: Total OMEq = Rescue OMEq + regular OMEq prescribed.
Abbreviation: PACU, Post Anaesthesia Care Unit.
TA B L E  5   Individual block performance data (n = 19). Values are 
median (IQR [range])
SSNB LSIB Total
Performance time (min) 3.2 (2.8- 3.6 
[2.3- 6.4])
3.0 (2.7- 3.3 
[2.3- 4.2])
7.2 (6.8- 7.8 
[6.3- 10.5])
Number of passes (n) 1 (1- 1 [1- 2]) 1 (1- 1 [1- 2]) 2 (2- 3 [2- 3])
Paraesthesia (n) 0 2 2




Abbreviations: SSNB, suprascapular nerve block; LSIB, lateral sagittal 
infraclavicular block.
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surgery.4,5 This has resulted in a plethora of studies investigating 
nerve blocks from nerve root to terminal nerve level. Our focus has 
been at the cord level and, therefore, on the infraclavicular block. 
The rationale for this is simple. One of the most distal approaches 
described for shoulder analgesia is by injection close to terminal 
nerves, namely the combination of suprascapular and axillary nerve 
blocks. These distal blocks may provide good post- operative anal-
gesia after shoulder arthroscopy, but their use in more extensive 
surgery is not recommended.15- 17 This is allegedly due to the contri-
butions of proximal branches from the axillary nerve, the subscapu-
lar and lateral pectoral nerves, all arising from the posterior and the 
lateral cord of the brachial plexus. Hence, the infraclavicular block 
allows blocking of all these nerves with a single injection and is the-
oretically expected to result in a denser block. The infraclavicular 
block dose was extrapolated by data from a recent minimum effec-
tive volume (MEV) publication,10 where we calculated a MEV50 of 
7.8 mL and estimated a MEV95 of 9.0 mL. However, in the current 
study, we opted for a higher volume (15 mL), to prevent the risk of 
inadequate post- operative pain coverage.
To our knowledge, the minimum effective dose for a successful 
SSNB is currently unknown. A lower volume for a successful block 
has been described,18 but the clinical analgesic effect of this ap-
proach remains unexplored. Nonetheless, we have previously shown 
that 4 mL ropivacaine 0.5% provided satisfying post- operative anal-
gesia after shoulder arthroscopy.9
Paracetamol and oxycodone were prescribed as regular medi-
cation, with morphine and oxycodone as rescue pain medications. 
However, prescription of a wider multimodal pain medication 
strategy could potentially have reduced OMEq consumption. 
Administration of adjuvants are known to prolong block duration of 
peripheral nerve blocks19 and in this study we opted for 4 mg dexa-
methasone administered intravenously. It is possible to speculate 
that a higher dose20 or a combination of adjuvants21,22 could have 
resulted in longer lasting blocks and thus lower total consumption 
of OMEq.
Our block combination does not aim to provide surgical anaes-
thesia, but rather provide effective post- operative analgesia. It is 
therefore not unexpected that a few patients experienced some level 
of pain in the PACU. Nevertheless, the median NRS in the immedi-
ate post- operative setting was 1 and rescue medication was only re-
quired in three patients with mean NRS of 3.5. Block duration could 
not be accurately determined since block effects wore off during 
the night and most patients struggled to exactly recall the time that 
sensory function was restored. However, they could place with ease 
the pain onset on a timeline. Therefore, the time from the retraction 
of the block needle to first report of pain was used as a surrogate 
for block duration. It is worth acknowledging that this could be a 
conspicuous underestimation of the real block duration, consider-
ing the broad discrepancy between time to first reported pain and 
time to reported restored sensory status (12.7 hours vs 19.8 hours). 
The consumption of extra OMEq, beyond the pre- scheduled anal-
gesic regime, is clearly concentrated between 8 and 24 hours after 
the arrival to the PACU and therefore after the effect of the blocks 
has worn off. As a result, even if no patients suffered from PONV 
in the PACU, five experienced opioid- induced nausea or vomiting. 
Further modifications including dose adjustments, type and dose of 
adjuvants applied, catheter- based techniques, as well as design of a 
more complex multimodal analgesic regime may prolong pain relief 
and thus improve NRS results and OMEq consumption.
Despite several modifications, no single intervention on the in-
terscalene technique seems to decrease the incidence of phrenic 
palsy below 27%.4 In the present study, we report one case of 
hemidiaphragmatic paralysis, which accounts for a 5% incidence. 
Unfortunately, the mechanisms for how the phrenic nerve became 
anaesthetised can only be speculated. In this patient (#8) the ultra-
sonographical visualisation of the SSN proved to be challenging and 
the nerve was eventually blocked in a more cranial position, closer 
to the cervical structures, with possible cranial spread to the phrenic 
nerve. Clinicians should be aware of this possibility and be vigilant 
during the ultrasonographic phase, in order to optimize the subse-
quent injection of local anaesthetic.
Our study presents some further limitations. The NRS scale is a 
validated pain scoring tool but relies on an accurate patient response. 
At times, it was challenging to assess average pain score during the 
day, as some patients struggled to recall pain levels and others 
struggled to understand the meaning of this score. To overcome this 
limitation, OMEq consumption was chosen as an additional primary 
aim. The option of patient- controlled analgesia (PCA) was consid-
ered but dismissed due to logistical issues. NRS assessments at 1, 3, 
6, 8 and 24 hours after the arrival to the PACU although arbitrary, 
are considered to be clinically relevant time points.
As an observational case series, this study carries some intrin-
sic limitations that would otherwise be addressed in a randomized 
control trial and therefore warrants further investigation. However, 
as both the NRS pain scores and the OMEq consumption during the 
first post- operative day were promising, this block combination ap-
pears comparable with other shoulder arthroplasty studies where 
interscalene blockade has been applied.23- 26
In summary, the combination of infraclavicular and suprascapular 
nerve blocks shows an encouraging post- operative analgesic profile 
after total shoulder arthroplasty. However, randomized controlled 
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